Followers | 195 |
Posts | 24425 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Monday, October 17, 2016 2:27:12 PM
As indicated before, the relationship with Cognate was fully disclosed in the disclosure documents. That's how Phase V found the information. The issue was, was the crossing of the NASDAQ rule material or immaterial enough for him to divest? Apparently not. And he maintained afterwards that he had confidence in the science here, which was not consistent with what Phase V was alleging.
So I have a hard time taking any comfort from anything Phase V has said so far, given the outcome myself, though no doubt Phase V's report did certainly crush the price and gave quite an opening to shorts to bash the company to a very low price. The end result is that I got to buy at extremely cheap prices. I feel very badly for the longs however, and sympathize, having been in companies I believed were quite solid, to see similar treatment from manipulators in the past. Manipulating stocks down, for profit is clearly a very easy, profitable gig, or it would not be so common in the biotech market. It's very easy to convince people that just about any stock is a scam, if one desires to take that route. Fear is a much easier emotion to inspire than confidence, and is the territory of scoundrels and politicians.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM